Keyword: Randall Stanicky

It was nearly two years ago that activist investors began urging Perrigo to hive off its specialty pharma unit. Now, it’s finally happening.

Billionaire David Tepper has permission to make an activist run at Allergan. Will he use it—and if so, how?

Just five months after Allergan’s CEO said the company wouldn’t break up, it’s reportedly weighing options for its women’s health unit.